IN SILICO MOLECULAR DOCKING AGAINST C-KIT TYROSINE KINASE AND ADME STUDIES OF 3-ETHYL-2-(2,4,5-TRIFLUOROPHENYLIMINO)- THIAZOLIDIN-4-ONE DERIVATIVES
Govind Jadhav, Prasad Kadam, Ganpat Nagargoje, Abhay Bondge, Shital Jadhav,
and Vijaykumar More*
Abstract
Thiazolidin-4-one derivatives have been hailed as “wonder nucleus”
due to their profound biological activities. A number of derivatives
with variable functional groups attached to the five-membered
heterocyclic ring which have been synthesized and further subjected to
molecular docking studies, against C-KIT Tyrosine kinase target
protein (1T46). The interactions, binding and affinity variations due to
differences in functional groups have been studied using ChemDraw
Ultra 7.0, RCSB – Protein Data Bank, BIOVIA Discovery Studio
Visualizer 2021, MGL AutoDock Tools, AutoDock Vina and Vina
Split software. The docking studies showed good interaction of the
synthesized molecules with the 1T46 target protein. The ADME studies of these molecules
have also been studied to identify which of the synthesized molecules have the potential to
cross the Human Intestinal lining (HIA), as well as the BBB barrier. Out of the 18 molecules
studied, 12 of them showed good potential to be absorbed by the intestine out of which only
one molecule was able to show potential to cross the BBB barrier. There were 4 molecules
that could not cross both the barrier. These studies could reveal which functionalities present
attached to the thiazolidin-4-one could assist in human intestinal absorption and the crossing
of the BBB barrier.
Keywords: Thiazolidin-4-one, Molecular Docking, ADME, HIA, BBB.
[Full Text Article]